외상으로 인한 진행성 출혈이 동반된 와파린 복용환자에서의 새로운 경구 항응고제의 적용

The traditional drug for anticoagulation in those with a high risk of thrombosis is a vitamin K antagonist, such as warfarin. On the other hand, this drug has several limitations and hemorrhagic complications. Recently, novel or non-vitamin K-dependent antagonist oral anticoagulants (NOACs) have bee...

Full description

Saved in:
Bibliographic Details
Published inJournal of acute care surgery pp. 33 - 37
Main Authors 예진봉, 설영훈, 이진영, 고승제, 최정희
Format Journal Article
LanguageKorean
Published 대한외상중환자외과학회 01.04.2018
Subjects
Online AccessGet full text
ISSN2288-5862
2288-9582
DOI10.17479/jacs.2018.8.1.33

Cover

More Information
Summary:The traditional drug for anticoagulation in those with a high risk of thrombosis is a vitamin K antagonist, such as warfarin. On the other hand, this drug has several limitations and hemorrhagic complications. Recently, novel or non-vitamin K-dependent antagonist oral anticoagulants (NOACs) have been developed to solve these problems. This paper presents a case of adaptation of NOAC for a warfarin anticoagulated patient with traumatic ongoing hemorrhages with a discussion of the clinical implications of NOAC. (J Acute Care Surg 2018;8:33-37) KCI Citation Count: 0
ISSN:2288-5862
2288-9582
DOI:10.17479/jacs.2018.8.1.33